CCJ vs. UEC: Which Uranium Stock Deserves a Place in Your Portfolio?

Cameco Corporation (CCJ) and Uranium Energy Corp. (UEC) are positioned to capitalize on the global nuclear energy resurgence, with uranium prices recovering to $73.50/lb amid ambitious expansion plans in India and the U.S. Cameco reported strong Q2 2025 results, with revenues up 47% to $634 million and adjusted EPS surging 410%, benefiting from diversified operations and fixed-price contracts. Conversely, Uranium Energy Corp. (UEC) posted no revenue and a loss in Q3 2025 as it strategically withholds sales while ramping up significant U.S. production capacity and advancing key projects. While both companies are exposed to long-term tailwinds, Cameco's current profitability, stable revenue streams, and more favorable valuation position it as a stronger investment compared to UEC's growth-focused, but presently unprofitable, profile.

Analysis

The uranium sector is benefiting from a strong long-term demand outlook, driven by significant nuclear capacity expansion plans in the United States and India, which has supported a price recovery to approximately $73.50 per pound. Within this context, Cameco (CCJ) and Uranium Energy Corp. (UEC) present contrasting investment profiles. Cameco, an established producer, demonstrated robust financial health in its Q2 2025 results, with revenue climbing 47% to CAD 877 million and adjusted EPS surging 410%. Crucially, its use of fixed-price contracts allowed its realized Canadian dollar price to increase 5% even as the U.S. dollar spot price fell 17%, highlighting a resilient business model further supported by its fuel services segment and a growing contribution from its Westinghouse stake. Conversely, UEC is a development-stage company that strategically withheld sales, resulting in zero revenue and an adjusted loss of six cents per share in its latest quarter amid a 73% surge in operating expenses. While UEC boasts a substantial U.S. resource portfolio, a debt-free balance sheet, and is advancing key production projects like Christensen Ranch, its valuation is exceptionally high with a forward price-to-sales multiple of 52.92X. Analyst estimates for UEC have been revised downward, in contrast to upward revisions for Cameco's fiscal 2025, positioning CCJ as the financially stronger and more conservatively valued entity at present.

Key Decisions for Investors

• Investors seeking exposure to the uranium up-cycle with a more defensive positioning should consider Cameco, given its current profitability, diversified revenue streams from fixed-price contracts and fuel services, and a comparatively lower valuation of 12.86X forward sales.
• Exercise caution with Uranium Energy Corp., as its premium valuation, current lack of revenue, widening losses, and downward analyst estimate revisions present significant risks that depend heavily on future operational success and higher spot uranium prices.
• Monitor UEC's progress in restarting and ramping up production at its Christensen Ranch operations, as successful execution is critical to justifying its growth-oriented valuation and shifting from a development-stage to a revenue-generating company.
• For Cameco, investors should track its ability to meet its 2025 production guidance of 22.4 million pounds and the performance of its Westinghouse segment, which is a key driver for its projected 6-10% compound annual growth in adjusted EBITDA over five years.